Antibacterial Drug Market

Global Antibacterial Drug Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2022-2028. The growing incidence of infectious diseases, aged population and rising demand for efficient and affordable antibacterial drugs are key drivers of Global Antibacterial Drugs Market.

Scope of Antibacterial Drug Market Reports –

Antibacterial drugs are chemical substance derived from bacterium that can inhibit the growth of microorganisms and cure bacterial infections. Antimicrobial drugs used in the treatment and prevention of bacterial infections. Antimicrobial drugs are also called as Antimicrobial Agents or Antibiotics. Antibacterial Drugs are classified into- Aminoglycosides, Macrolides, Tetracyclines, Chloramphenicol and Lincomycins.

Antibacterial drugs are produced by either by natural fermentation or by chemical synthesis. Those are derived from substances produced by various microorganism species (bacteria, fungi, actinomycetes, virus) are known as ‘Antibiotics’ but not all antibacterial agents are antibiotics some are produced solely by chemical synthesis in laboratory, e.g. sulfonamides and fluoroquinolones. β-lactams have the biggest market in antibacterial drugs market. Out of which, carbapenems have the maximum growing market. This is due to increased consumption of this drug, replacing others. Some Antibacterial drugs cause allergic reactions.The symptoms of allergic reaction isshortness of breath, rash, hives, itching, swelling of lips and face, fainting and many more.

Global Antibacterial Drug Market is segmented on the basis of Drug class, Route of administration,End user,Drug mechanisms and Geography. Based upon Drug class Global Antibacterial Drug Market is classified as Sulfonamides, B – lactams, Aminoglycosides, Quinolones, Macrolides, Tetracycline, Phenicols and Others. Based on the Route of Administration Global Antibacterial Drug Market is classified into Oral, Parenteral and Others. On the basis of End users Global antibacterial Drug Market is classified into Hospital Pharmacies, Retail Pharmacies, Online Sales, Drug Stores, Clinics and Others. On the basis of Drug mechanism the Global Antibacterial Drug Market is segmented into Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, Nucleic Acid Inhibitors, Folic Acid synthesis inhibitors and Mycolic Acid synthesis inhibitors.

The regions covered in Global Antibacterial Drug Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Antibacterial Drug Market Key Players –

• Pfizer Inc.
• Sanofi
• GlaxoSmithKline Plc. (GSK)
• Allergen Plc.
• Novartis Ag
• AstraZeneca
• Bayer AG
• Merck & Co. Inc.
• Allecra Therapeutics
• R-Pharm Group
• Melinta Therapeutics LLC
• MicuRx
• TenNor Therapeutics Ltd
• Venatorx Pharmaceuticals Inc.
• Johnson & Johnson
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• AbbVie Inc.
• Spero Therapeutics
• F. Hoffmann-La Roche Ltd.
• Mylan
• Sandoz International GmbH
• Xellia Pharmaceuticals
• AuroMedics Pharma LLC
• Theravance Biopharma

Antibacterial Drug Market Segmentation –

By Drug Class Analysis

• Sulfonamides,
• B – lactams, Aminoglycosides
• Quinolones
• Macrolides
• Tetracycline
• Phenicols
• Others

By Route of Administration Analysis

• Oral
• Parenteral
• Others

By End User Analysis

• Hospital Pharmacies
• Retail Pharmacies
• Online Sales
• Drug Stores
• Clinics
• Others

By Drug Mechanism Analysis

• Cell Wall Synthesis Inhibitors
• Protein Synthesis Inhibitors
• Nucleic Acid Inhibitors
• Folic Acid synthesis inhibitors
• Mycolic Acid synthesis inhibitors
• Others

 

Market Dynamics –

Rising geriatric population, increasing demand for efficient, affordable Antibacterial drugs and increasing number of Multi-Drug Resistant (MDR) bacterial strains are key drivers for Global Antibacterial Drugs Market. Also,increased prevalence of infectious diseases and development of innovative molecules or treatment are driving the Global Antibacterial Drugs Market. However, increasing number of generic drugs for antibacterial therapy, expiry of patent andless R&D expenditure are restricts the growth of Global Antibacterial market. Innovation of some novel compounds like Relacin with improved efficacy, reduced time for action and fewer side effects are expected to offer good opportunity for growth of antibacterial drugs market in the future. Moreover, newadvancesdone in routes of administration in several developing and developed regions are likely to boost the acceptance of Antibacterial drugs.

Regional Analysis–

North America is likely to achieve the largest share of the Global Antibacterial Drug Market in terms of revenue and expected to hold the position followed by Europe region due to rising number of multi-drug resistant bacterial strains in these regions. Asia-Pacific is anticipated to grow at higher rate due to large patient population, increasing bacterial infections such as tuberculosis, pneumonia, tetanus and others and growing healthcare infrastructure. Increased expenditure for research & development activities in developing countries leads to become a beneficial market for Antibacterial drugs. Furthermore, increase in awareness of disease and government initiatives for improving health care facilities are expected to boost the regional market to a certain extent.

By Regional & Country Analysis

North America, US, Mexico, Chily, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, South Korea, Japan, India, Southeast Asia, Latin America, Brazil, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Report Analysis	Details
Historical data	2018-2021
Forecast Period	2022 - 2028
Market Size in 2020:	XX
Base year considered	2021
Forecast Period CAGR %:	XX
Market Size Expected in 2028:	XX
Tables, Charts & Figures:	175
Pages	200
Antibacterial Drug manufacturers	Pfizer Inc., Sanofi, GlaxoSmithKline Plc. (GSK), Allergen Plc., Novartis Ag, AstraZeneca, Bayer AG, Merck & Co. Inc., Allecra Therapeutics, R-Pharm Group, Melinta Therapeutics LLC, MicuRx, TenNor Therapeutics Ltd, Venatorx Pharmaceuticals Inc., Johnson & Johnson, Bristol-Myers Squibb Company, Eli Lilly and Company, AbbVie Inc., Spero Therapeutics, F. Hoffmann-La Roche Ltd., Mylan, Sandoz International GmbH, Xellia Pharmaceuticals, AuroMedics Pharma LLC, Theravance Biopharma , and others.
Segments Covered	By Drug Class Analysis, By Route of Administration Analysis, By End User Analysis, By Drug Mechanism Analysis
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Benefits –

• Global Antibacterial Drug Market report covers in depth historical and forecast analysis.
• Global Antibacterial Drug Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
• Global Antibacterial Drug Market report helps to identify opportunities in market place.
• Global Antibacterial Drug Market report covers extensive analysis of emerging trends and competitive landscape.